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Objective To evaluate red blood cell (RBC) transfusion practices in preterm neo-
nates before and after protocol change.
Methods All preterm neonates (<32 weeks of gestation) admitted between 2008
and 2017 at our neonatal intensive care unit were included in this retrospective
study. Since 2014, a more restrictive transfusion guideline was implemented in
our unit. We compared transfusion practices before and after this guideline
change. Primary outcome was the number of transfusions per neonate and the
percentage of neonates receiving a blood transfusion. Secondary outcomes were
neonatal morbidities and mortality during admission.
Results The percentage of preterm neonates requiring a blood transfusion was
375% (405/1079) before and 327% (165/505) after the protocol change (P = 0040).
The mean number of transfusions given to each transfused neonate decreased from
293 (standard deviation (SD) – 226) to 220 (SD –129) (P = 0007). We observed
no association between changes in transfusion practices and neonatal outcome.
Conclusion The use of a more restrictive transfusion guideline leads to a reduc-
tion in red blood cell transfusions in preterm neonates, without evidence of an
increase in mortality or short-term morbidity.
Key words: erythrocyte transfusion, neonate, preterm.
Introduction
Blood products, in particular red blood cell (RBC) transfu-
sions, are frequently administered in preterm neonates
during their stay in the neonatal intensive care unit
(NICU). Up to 90% of extreme preterm neonates receive
one or more transfusions in the first few weeks of life
[1, 2]. RBC transfusions in neonates are mostly adminis-
tered prophylactically, when haemoglobin (Hb) levels
drop below a certain level (transfusion trigger). However,
the optimal transfusion trigger in neonates is not known
and wide variance in Hb triggers and transfusion guideli-
nes is used internationally [1]. In the past decade, studies
comparing liberal vs. restrictive transfusion guidelines in
neonates showed conflicting results, in terms of short-
term outcome as well as long-term neurodevelopmental
outcome [3–6]. Various studies, both in adults and in
children admitted to intensive care units, reported that
restrictive RBC transfusion guidelines decrease transfusion
requirements and the intrinsically associated patient bur-
den, costs and labour. Importantly, the restrictive transfu-
sion strategies were not associated with an increase in
adverse outcomes [7]. On the contrary, several studies
suggest that less RBC transfusions should also reduce pos-
sible transfusion-related immunomodulation [8, 9]. There-
fore, the lack of evidence for inferiority, together with the
default advantages of restriction, led to ditto recommen-
dations in the national transfusion guideline in 2014. We
accordingly adapted our local transfusion protocol from a
liberal to a more restrictive transfusion strategy.
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The objective of this study was to evaluate the effect of
the protocol change on the RBC transfusion practices and
investigate the effect on neonatal morbidity and mortality.
Methods
Study design and population
This retrospective observational cohort study was con-
ducted at the Leiden University Medical Centre (LUMC), a
tertiary care centre in the Netherlands. We included all
consecutive preterm neonates admitted to our NICU
between 01-01-2008 and 31-12-2016, with gestational
age at birth between 24 + 0 and 31 + 6 weeks.
The neonates were divided into two cohorts based on
their year of birth, before and after the protocol change
made in 2014. The study was approved by the Leiden
Medical Ethics Committee (institutional review board) in
July 2017 (G17045).
Changes in protocol
Before 2014, the guidelines used in the LUMC for RBC
transfusions in neonates were based on the Dutch
national guidelines from 2004 [10]. Since 2014, our local
guideline was changed, based on a Cochrane systematic
review [11]. The transfusion guidelines before 2014 were
mainly based on specific Hb triggers (arterial or venous
blood samples) and the need and type of respiratory sup-
port. The transfusion guidelines after 2014 were based on
lower Hb triggers (also arterial or venous blood samples)
in association with both the need of respiratory support
and postnatal age in weeks (Table 1). The transfusion
dosage, velocity of infusion and irradiation requirements
remained the same during the two study periods. Routine
transfusion dosage was 15 ml/kg administered in 3 h,
using irradiated and leucocyte-depleted product.
Outcome measures
The primary outcome was the number of neonates requir-
ing a RBC transfusion and the number of RBC transfu-
sions per neonate. The secondary outcomes were changes
in neonatal morbidities and mortality during admission.
Data were furthermore analysed according to gestational
age at birth and week of life. We recorded the following
neonatal variables, including respiratory distress syn-
drome (RDS) defined as respiratory failure requiring ven-
tilator support and surfactant treatment, severe
intraventricular haemorrhage (IVH grade 3 or 4), cystic
periventricular leukomalacia (PVL grade 2 or 3), symp-
tomatic patent ductus arteriosus (PDA) requiring medical
treatment (indomethacin or ibuprofen) or surgical closure,
necrotizing enterocolitis (NEC) ≥ stage 2 [12], proven
neonatal sepsis defined as a clinically ill neonate with a
positive bacterial blood culture and neonatal mortality
and length of stay at our NICU. The recorded short-term
morbidities were not indications for transfusions, but used
as secondary outcomes for this study.
Sample size
In order to detect 10% difference in transfusions before
and after the protocol change (assuming 40% in the
cohort before and 30% in the cohort after 2014), with a
power of 80% and type one error of 5%, the sample size
was estimated to be at least 354 neonates per cohort.
Statistical analysis
Results are expressed as percentages, mean (standard devi-
ation (SD)) for normally distributed values (as calculated
for with the Shapiro–Wilk test) or median (interquartile
range (IQR)) for nonnormally distributed values. Results of
categorical variables were compared using the chi-squared
test, whereas the independent Student’s t-test and Mann–
Whitney U-test were used for normally and nonnormally
distributed continuous variables, as appropriate. A P-value
<005 was considered to indicate statistical significance.
All statistical analyses were performed using SPSS version
230 (IBM, Chicago, IL, USA).
Results
A total of 1584 preterm neonates delivered before
32 weeks of gestation were admitted to our NICU between
Table 1 (a) Haemoglobin transfusion triggers before guideline change in
2014. (b) Haemoglobin transfusion triggers after guideline change in
2014
Respiratory support g/dl
(a) Transfusion guideline before 2014
Mechanical ventilation <13
CPAP and/or oxygen <115






(b) Transfusion guideline after 2014
Day 0–6 (week 1) <115 <10
Day 7–13 (week 2) <10 <85
Day ≥ 14 (week ≥ 3) <85 <75a
CPAP, continuous positive airway pressure.
aAfter postnatal age ≥ 28 days, the recommended transfusion trigger
was <7 g/dl (45 mmol/l).
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1 January 2008 and 31 December 2016, of which 1079
in the first study period (01/01/2008-31/12/2013) and
505 in the second study period (01/01/2014-31/12/2016).
The baseline characteristics of all included neonates from
both cohorts are presented in Table 2. In the second
period, significantly more children were born by cae-
sarean section.
Primary outcome
The percentage of neonates receiving a RBC transfusion
decreased significantly from 375% (405/1079) in the first
period and 327% (165/505) in the second period
(P = 0040). The mean number of transfusions given to
each transfused neonate decreased from 293 (– 226)
transfusions per neonate in the first study period to 220
(– 129) in the second period (P = 0007).
Secondary outcomes
In both cohorts, gestational age at birth was related to
the need for RBC transfusions (Figs. 1 and 2). We found
no difference in percentage of neonates requiring a trans-
fusion nor in number of transfusions per neonate before
and after protocol changes, when analysed by gestational
age at birth.
RBC transfusions are mostly administered in the first
week of life (Fig. 3). In the second study period, the need
for RBC transfusion was significantly lower in the third
week (P < 0001) and fourth week of life (P = 0036), but
not in the first 2 weeks.
Table 3 shows the incidence of neonatal morbidity and
mortality in both cohorts, both in the overall group of
included neonates and in the subgroup receiving at least
one RBC transfusion. When comparing the study periods,
a significant decrease in incidence of severe IVH was
found. In the second study period, the length of
hospitalization was significantly higher compared to the
first period.
Therefore, we calculated the number of transfusions
per 100 admission days. The number of RBC transfusions
per 100 days of hospitalization was 53 (SD – 124) in the
first period and 27 (SD – 74) per 100 days in the second
period (P < 0001). For the neonates who received at least
one RBC transfusion, the number of transfusions per
100 days of hospitalization was 139 (SD –169) in the
first period and 82 (SD –110) in the second period
(P < 0001).




(n = 505) P-value
Male gender 581 (538%) 271 (537%) 0957
Gestational age (in weeks) 29 (24-31) 29 (24-31) 0669
Inborna 968 (897%) 463 (917%) 0236
Birthweight (in grams) 1259 (375) 1257 (377) 0921
SGAb 100 (93%) 38 (75%) 0293
Caesarean section 510 (473%) 267 (529%) 0052
Multiple birth 448 (415%) 194 (384%) 0249
Values given as mean (SD), median (range) or n (%).
aInborn: born in the LUMC.
bSGA: small for gestational age (birthweight below the 10th centile according to Dutch neonatal birthweight curves [28]).
Fig. 1 Percentage of neonates receiving RBC transfusion (Y-axis) per
gestational age at birth in weeks (X-axis), before and after guideline
change.
Fig. 2 Mean number of transfusions per neonate (Y-axis) per gestational
age at birth in weeks (X-axis), before and after guideline change.
© 2018 The Authors.
Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion
Vox Sanguinis (2019) 114, 57–62
Restricting neonatal blood transfusions 59
Discussion
In this large retrospective single centre study in more
than 1500 very preterm neonates, we found a significant
decrease in the rate of RBC transfusions. Since the intro-
duction in 2014 of a more restrictive RBC transfusion
guideline, the rate of neonates requiring a RBC transfu-
sion dropped from 375 to 327% and the mean number
of transfusions per transfused neonates was reduced from
293 to 220. The reduction in RBC transfusions using a
more restrictive guideline did not result in an increase in
mortality or morbidity. Recently, a possible association
has been reported between red blood cell transfusions and
NEC (transfusion-associated NEC: TANEC [13–15]). How-
ever, the causative relation is controversial and has not
been proven yet. In this study, we found no significant
changes in the incidence of NEC despite reduction in
blood transfusions. Importantly, our study was not pow-
ered to detect changes in the incidence of NEC.
Various factors, besides the protocol changes, could
have contributed to this decrease. Increased awareness of
the possible adverse effects of RBC transfusions in the lat-
ter years may have increased the adherence to transfusion
guidelines and reduced the rate of protocol violation
(both effects were not measured in this study). Several
studies have shown that strict adherence to transfusion
protocols reduces the number of RBC transfusions in pre-
term neonates [16, 17].
Also, the reduced transfusion rate in the latter period
could be related to an increased awareness on the delete-
rious impact of repeated blood testing on anaemia of pre-
maturity [18, 19]. Reducing the amount of blood drawn
for laboratory testing in very preterm neonates reduces
the risk of iatrogenic blood loss and the number of RBC
transfusion [20, 21].
Another crucial factor on the Hb level at birth and the
need for RBC transfusions is the timing of cord clamping
at birth. Various studies have shown that delaying cord
clamping will result in a higher Hb level at birth and
reduce the initial need for RBC transfusions [22].
Although our local guideline underscores the importance
of delayed cord clamping, the timing of cord clamping is
left to the discretion of the attending obstetrician, and the
timing of cord clamping was unfortunately not routinely
registered during the study period. As reported here
above, it is conceivable that also other factors, besides
the protocol change, may have contributed to the reduc-
tion in RBC transfusion. The baseline characteristics of
the two cohorts were almost similar, except for a decrease
in severe IVH and a longer period of hospitalization after
the protocol change. The reduced incidence of severe IVH
can be attributed to multiple factors. The longer stay in
the more recent period may have led to an
Fig. 3 Percentage of neonates requiring a blood transfusion in the ﬁrst
4 weeks of life and thereafter.
Table 3 Transfusion requirement and neonatal outcomes before and after transfusion guideline changes
All neonates









(n = 165) P-value
NEC 37% 51% 0181 59% 85% 0254
Proven sepsis 242% 263% 0357 437% 442% 0917
PDA 132% 129% 0874 276% 327% 0224
RDS 375% 364% 0699 641% 624% 0754
Severe IVH (grade 3/4) 76% 32% 0000 151% 48% 0001
Cystic PVL (≥ grade 2) 10% 16% 0337 20% 30% 0431
Mortality 81% 55% 0072 122% 73% 0084
Hospitalization, median number of days (IQR) 12 (5–27) 14 (7–32) 0001 29 (18–42) 41 (21–56) <0001
Receiving a RBC transfusion 375% 327% 0040 100% 100% -
Number of transfusions per neonate 111 (– 199) 072 (– 127) 0009 293 (– 226) 220 (– 129) 0007
Number of transfusions per 100 days admission, mean 53 (– 124) 27 (– 74) <0001 139 (– 169) 82 (– 110) <0001
© 2018 The Authors.
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underestimation of the effects of restrictive transfusion
guidelines since one could argue that the longer a neo-
nate is admitted to a NICU, the sicker the neonate could
be and the more at risk a neonate is for receiving a trans-
fusion. We therefore calculated the rate of RBC transfu-
sions per 100 hospitalization days and showed a stronger
impact of restrictive transfusion guidelines on the reduc-
tion in transfusions.
This study also confirmed the positive correlation
between extreme prematurity and need for RBC transfu-
sions. The blood sparing effect of a more restrictive trans-
fusion protocol was particularly pronounced in week 3
and 4 after birth, and not so much in the first 2 weeks of
life. This difference in effect is probably due to the differ-
ences in triggers for blood transfusion between the two
guidelines. The trigger for blood transfusion in week 3
and 4 was much lower compared to the initial guideline.
We found no difference in the need of transfusions when
analysed by gestational age at birth between the two peri-
ods. The lack of association between gestational age and
transfusions could be due to a limited sample size since
our study was not powered to detect differences related to
gestational age at birth.
To date, international consensus on the optimal
guideline for RBC transfusion in neonates is lacking
and different protocol and transfusion triggers are being
used around the world. The lack of consensus is partly
due to contradicting results of various studies. Bell
et al. [12] suggested that liberal RBC transfusions
improved the short-term neonatal outcome, but these
findings were not confirmed in a larger study by Kir-
palani et al. [3] (PINT study). Chen et al. [17] found an
significant decrease in chronic lung disease due to
restrictive transfusion threshold, without other
significant changes in morbidity. Importantly, only one
study assessed the effect of restrictive vs. liberal trans-
fusions on the long-term neurodevelopmental outcome.
Although no major differences were found, a borderline
statistical significant difference in cognitive delay
favouring the liberal strategy was reported [4]. In addi-
tion, Nopoulos et al. [23] showed that RBC transfusions
affected the long-term outcome of premature infants,
inflicting reduced brain volumes especially in those
who were transfused with a liberal strategy. In the
Cochrane systematic review, Whyte and Kirpalani [11]
concluded that the use of restrictive as compared to
liberal transfusion guidelines resulted in modest reduc-
tions in exposure to transfusion, without a significant
impact on death or major morbidities. In 2014, Ibrahim
et al. [24] performed a meta-analysis which reflects the
results of the Cochrane review. These partly contradict-
ing results highlight the need for more studies and
clearer evidence to reach global consensus on transfu-
sion thresholds and improve neonatal care [2, 25]. Two
large prospective studies (ETTNO study [26] and TOP
study [27]) comparing liberal vs. restrictive RBC trans-
fusion strategies are currently being conducted. These
studies also compare neurological outcomes up to
2 years of age. The results of these studies are eagerly
awaited and will hopefully provide more information
on the impact of different transfusion thresholds, con-
tributing to an international consensus.
In conclusion, our study shows that the use of a more
restrictive transfusion protocol has led to a reduction in
RBC transfusions without an increase in morbidity or
mortality. In addition to optimizing neonatal care, reduc-
ing the amount of transfusions also reduces the costs of
neonatal medical care.
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